Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1Breast 1

Conditions

Ovarian Neoplasms 12Breast Neoplasms 10Endometrial Neoplasms 7Pancreatic Neoplasms 5Neoplasms 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Colorectal Neoplasms 3Carcinoma, Ovarian Epithelial 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Carcinoma, Renal Cell 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Neoplasms by Site 1Multiple Myeloma 1Melanoma 1Lymphoma 1Inflammation 1Hereditary Sensory and Autonomic Neuropathies 1Hematologic Neoplasms 1

Interventions

ribociclib 1palbociclib 1olaparib 1alectinib 1Paclitaxel 1Fulvestrant 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Digestive System Neoplasms × palbociclib × Gynecologic × Clear all
NCT05238922 2026-04-14

Study of INCB123667 in Subjects With Advanced Solid Tumors

Incyte Corporation

Phase 1 Recruiting
604 enrolled
BreastGastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡